Articles published in Nuclear Medicine & Radiation Therapy have been cited by esteemed scholars and scientists all around the world.
Nuclear Medicine & Radiation Therapy has got h-index 12, which means every article in Nuclear Medicine & Radiation Therapy has got 12 average citations.
Following are the list of articles that have cited the articles published in Nuclear Medicine & Radiation Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
50 | 52 | 63 | 62 | 11 | 17 | 49 |
Research, Review articles and Editorials |
212 | 112 | 0 | 0 | 0 | 0 | 0 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
545 | 458 | 0 | 0 | 0 | 0 | 0 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 22 |
Citations received as per Google Scholar, other indexing platforms and portals |
757 | 570 | 69 | 80 | 82 | 74 | 61 |
Journal total citations count | 706 |
Journal impact factor | 2.03 |
Journal 5 years impact factor | 1.8 |
Journal cite score | 1.98 |
Journal h-index | 12 |
Journal h-index since 2019 | 9 |
Whittle, Sarah B., Valeria Smith, Erin Doherty, Sibo Zhao, Scott McCarty, and Peter E. Zage. "Overview and recent advances in the treatment of neuroblastoma." Expert review of anticancer therapy 17, no. 4 (2017): 369-386. |
|
Babu, Manas. "Radiation risks in urologic practice." Astrocyte 2, no. 2 (2015): 77. |
|
Rezaei, Sahar, Pardis Ghafarian, Abhinav K. Jha, Arman Rahmim, Saeed Sarkar, and Mohammad Reza Ay. "Joint compensation of motion and partial volume effects by iterative deconvolution incorporating wavelet-based denoising in oncologic PET/CT imaging." Physica Medica 68 (2019): 52-60. |
|
Yamamoto, Takaya, Noriyuki Kadoya, Yuko Shirata, Tomohiro Kaneta, Masashi Koto, Rei Umezawa, Youjirou Ishikawa et al. "Formula corrected maximal standardized uptake value in FDG-PET for partial volume effect and motion artifact is not a prognostic factor in stage I non-small cell lung cancer treated with stereotactic body radiotherapy." Annals of nuclear medicine 29, no. 8 (2015): 666-673. |
|
Santos-de-Frutos, Karla, and Nabil Djouder. "When dormancy fuels tumour relapse." Communications Biology 4, no. 1 (2021): 1-12. |
|
Providência, L., Domingues, I., & Santos, J. (2021). An Iterative Algorithm for Semisupervised Classification of Hotspots on Bone Scintigraphies of Patients with Prostate Cancer. Journal of Imaging, 7(8), 148.lauraprovid@hotmail.com |
|
Georgiou, M., Kuker, R. A., Studenski, M., Ahlman, P. P., Witte, M., & Portelance, L. (2021). Lung Shunt Fraction Calculation Using 99mTc-MAA SPECT/CT Imaging for 90Y Microsphere Selective Internal Radiation Therapy of Liver Tumors. |
|
Asadian, S., Mirzaei, H., Kalantari, B. A., Davarpanah, M. R., Mohamadi, M., Shpichka, A., ... & Vosough, M. (2020). ?-radiating radionuclides in cancer treatment, novel insight into promising approach. Pharmacological Research, 105070. |
|
Fleming, R. M., & Fleming, M. R. (2020). FMTVDM-Finally Opens the Doorway from Qualitative to Quantitative Measurement and Treatment of Heart Disease. J Cardiovasc Med Cardiol, 7(2), 060-062. |
|
Fleming, R. M., Fleming, M. R., de la Fuente, L. M., & Peñaloza, F. E. (2020). The Impact of Low Carb-KETO Diets on CAD-Why more Research is needed. Journal of Cardiovascular Medicine and Cardiology, 7(2), 110-120. |
|
Fleming, R. M. (2019). Unmasking Hidden Recurrent Cancers using FMTVDM/BEST: The Fleming Cancer Hypothesis. Int J Womens Health Well-ness, 5(094), 2474-1353. |
|
Fleming, R. M. (2019). Unmasking Hidden Recurrent Cancers using FMTVDM/BEST: The Fleming Cancer Hypothesis. Int J Womens Health Well-ness, 5(094), 2474-1353. |
|
Fleming, R. M. (2019). Unmasking Hidden Recurrent Cancers using FMTVDM/BEST: The Fleming Cancer Hypothesis. Int J Womens Health Well-ness, 5(094), 2474-1353. |
|
Fleming, R. M., Fleming, M. R., Chaudhuri, T. K., Dooley, W. C., & Mc Kusick, A. (2019). FMTVDM/BEST©? Imaging for Women with Breast Implants and Dense Breasts. Int J Womens Health Wellness, 5(092), 2474-1353. |
|
Fleming, R. M., Fleming, M. R., Chaudhuri, T. K., & Kusick, A. M. (2019). FMTVDM© â „—Provides the First Patented Quantification of Myocardial Perfusion Imaging (MPI) Yielding Theranostic Benefit for Individuals with Suspected Coronary Artery Disease (CAD). Biomedical Journal of Scientific & Technical Research, 13(5), 10329-10332. |
|
Fleming, R. M., Fleming, M. R., Chaudhuri, T. K., & Kusick, A. M. (2019). FMTVDM© â „—Provides the First Patented Quantification of Myocardial Perfusion Imaging (MPI) Yielding Theranostic Benefit for Individuals with Suspected Coronary Artery Disease (CAD). Biomedical Journal of Scientific & Technical Research, 13(5), 10329-10332. |
|
Contreras, Carlos. "Mathematical modelling of the effect of low-dose radiation on the G2/M transition and the survival fraction via the ATM/Chk2 pathway." (2020). |
|
Bell, Clayton, Kyle Potts, Mary Hitt, Desmond Pink, Jack Tuszynski, and John D. Lewis. "Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinoma." Cancer Letters (2021). |
|
Bell, Clayton James. "CR42-24, a Novel Colchicine Derivative, as a Therapy for Bladder Cancer." (2018). |
|
Nair, Jyothi, Poorvaja Muley, and Shilpee Dutt. "Therapy induced senescence and its implications in cancer." Cancer 1, no. 2 (2017): 1-2. |
|
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report